Ultimate International, Inc.
This randomized, triple-blind, placebo-controlled study will evaluate the efficacy of Diaberine, a berberine-based nutraceutical, in aiding blood sugar regulation and metabolism in 80 participants over 24 weeks.
Inclusion Criteria: * Male or female. * BMI: 27-35 kg/m2 * HbA1c of 5.7%-6.4% (determined by prescreening blood test) * Be generally healthy * Willing to refrain from taking any products, prescription medications, or supplements that target blood sugar regulation or metabolism during the test period. * Willing to maintain their current diet, sleep schedule, and activity level for the duration of the study. Exclusion Criteria: * Diagnosed with Type 2 diabetes mellitus (T2DM) and have been prescribed metformin, insulin, Sulfonylureas, Meglitinides, SGLT2 inhibitors and/or GLP-1 medications in…
Participants will take one capsule three times daily, 15 minutes prior to meals, over a 24-week period.
Participants will take one capsule three times daily, 15 minutes prior to meals, over a 24-week period.
Arctuva estimate
Verify or correct the compensation shown for this listing.